Avenu Medical Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
13
- Latest Deal Type
-
M&A
Avenu Medical General Information
Description
Developer of a vascular therapeutic device created to pursue unmet clinical needs in the vascular access markets. The company's device is an innovative, image-guided, single catheter system used to percutaneously create an arteriovenous fistula for hemodialysis access, thereby enabling hospitals to treat patients with chronic kidney diseases.
Contact Information
Website
www.avenumedical.com(Operating Subsidiary)
Corporate Office
- 27123 Calle Arroyo
- Suite 2101
- San Juan Capistrano, CA 92675
- United States
Corporate Office
- 27123 Calle Arroyo
- Suite 2101
- San Juan Capistrano, CA 92675
- United States
Avenu Medical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Merger/Acquisition | 01-Nov-2020 | 000.00 | Completed | Generating Revenue | ||
6. Debt - PPP | 03-May-2020 | 00000 | 000.00 | Completed | Generating Revenue | |
5. Later Stage VC | 31-Oct-2018 | 0000 | 000.00 | Completed | Generating Revenue | |
4. Later Stage VC (Series C) | 15-Feb-2017 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
3. Later Stage VC (Series B) | 15-Dec-2015 | 00.00 | 000.00 | 000.00 | Completed | Startup |
2. Early Stage VC (Series A) | 03-May-2011 | $1.44M | $2.44M | 00.000 | Completed | Startup |
1. Seed Round | 28-Sep-2010 | $1M | $1M | 000 | Completed | Startup |
Avenu Medical Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | 0,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00.00 | |
Series B | 0,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00.00 | |
Series A | 5,500,000 | $0.001000 | $1 | $1 | 1x | $1 | 25.85% | |
Series S | 2,500,000 | $0.001000 | $0.4 | $0.4 | 1x | $0.4 | 11.75% |
Avenu Medical Comparisons
Industry
Financing
Details
Avenu Medical Competitors (16)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
CardioFocus | Venture Capital-Backed | Marlborough, MA | 00 | 00000 | 00000000000 | 00000 |
Laminate Medical Technologies | Venture Capital-Backed | Tel Aviv, Israel | 00 | 0000 | 00000000000 | 0000 |
Inari Medical | Formerly VC-backed | Irvine, CA | 0000 | 00000 | 00000000 | 00000 |
Atricure | Formerly VC-backed | Mason, OH | 0000 | 00000 | 000000000 00 | 00000 |
Peripal | Venture Capital-Backed | Zurich, Switzerland | 0 | 00.00 | 0000000000 0 | 00.00 |
Avenu Medical Patents
Avenu Medical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210177508-A1 | Devices and methods for the creation of an inter-atrial shunt for the treatment of congestive heart failure | Pending | 12-Dec-2019 | 0000000000 | 00 |
US-11793623-B1 | Systems and methods for percutaneously placing biologic grafts at a procedural site | Active | 14-Oct-2019 | 00000000 | 0 |
US-20240016597-A1 | Systems and methods for percutaneously placing biologic grafts at a procedural site | Pending | 14-Oct-2019 | 00000000 | |
US-20200038026-A1 | Fixation of vessels for percutaneous fistula creation | Active | 03-Aug-2018 | 000000000 | |
US-11083460-B2 | Fixation of vessels for percutaneous fistula creation | Active | 03-Aug-2018 | A61B17/1227 | 00 |
Avenu Medical Executive Team (7)
Name | Title | Board Seat |
---|---|---|
Mark Ritchart | Co-Founder, Board Member, Chief Executive Officer & President | |
Jeffrey Hull | Co-Founder & Chief Medical Officer |
Avenu Medical Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Mark Ritchart | Avenu Medical | Co-Founder, Board Member, Chief Executive Officer & President | 000 0000 |
Avenu Medical Signals
Avenu Medical Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Pond Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
Avenu Medical FAQs
-
When was Avenu Medical founded?
Avenu Medical was founded in 2010.
-
Who is the founder of Avenu Medical?
Mark Ritchart, Eddie Chang, Steve Parker MD, and Jeffrey Hull are the founders of Avenu Medical.
-
Where is Avenu Medical headquartered?
Avenu Medical is headquartered in San Juan Capistrano, CA.
-
What is the size of Avenu Medical?
Avenu Medical has 13 total employees.
-
What industry is Avenu Medical in?
Avenu Medical’s primary industry is Therapeutic Devices.
-
Is Avenu Medical a private or public company?
Avenu Medical is a Private company.
-
What is Avenu Medical’s current revenue?
The current revenue for Avenu Medical is 000000.
-
How much funding has Avenu Medical raised over time?
Avenu Medical has raised $37.4M.
-
Who are Avenu Medical’s investors?
Pond Capital has invested in Avenu Medical.
-
Who are Avenu Medical’s competitors?
CardioFocus, Laminate Medical Technologies, Inari Medical, Atricure, and Peripal are some of the 16 competitors of Avenu Medical.
-
When was Avenu Medical acquired?
Avenu Medical was acquired on 01-Nov-2020.
-
Who acquired Avenu Medical?
Avenu Medical was acquired by Medtronic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »